| Patents for C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022) |
|---|
| 02/25/2004 | EP1390034A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists |
| 02/25/2004 | CN1478084A Compounds useful in treatment of inflammatory diseases |
| 02/25/2004 | CN1478074A Cyclohexyl (alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 02/19/2004 | WO2004014851A2 Tyrosine kinase inhibitors |
| 02/19/2004 | US20040034018 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders |
| 02/19/2004 | US20040033969 Such as penicillin G coupled to 2'deoxyazithromycin; drug delivery |
| 02/19/2004 | DE10234697A1 Neue Verbindungen zur Stimulation des Nervenwachstums, zur Inhibition der Narbengewebsbildung und/oder Reduktion eines Sekundärschadens Novel compounds for stimulation of nerve growth, to inhibition of scar tissue formation and / or reduction of secondary damage |
| 02/12/2004 | WO2004012649A2 Novel compounds for stimulation of nerve growth, for the inhibition of scar tissue formation and/or reduction of secondary damage |
| 02/12/2004 | US20040029850 Central nervous system disorders; antidepressants; bipolar disorders; rhematic diseases |
| 02/10/2004 | CA2108903C Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 02/04/2004 | CN1473053A High-density lipoprotein-cholesterol level elevating agent |
| 01/29/2004 | WO2004009530A1 Process for production of high-purity enamines |
| 01/13/2004 | US6677332 Amide-substituted piperidine or azepine derivatives to treat drug abuse and tinnitus |
| 01/02/2004 | EP1373188A1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics |
| 01/01/2004 | US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device |
| 12/31/2003 | WO2003068980A3 Method for extracting a macrolide from biomatter |
| 12/24/2003 | WO2003105833A1 Formulation of nefopam and its use in the treatment of pain |
| 12/24/2003 | WO2003105832A1 Use of nefopam for the treatment of nausea or emesis |
| 12/24/2003 | CA2489315A1 Formulation of nefopam and its use in the treatment of pain |
| 12/24/2003 | CA2489306A1 Use of nefopam for the treatment of nausea or emesis |
| 12/23/2003 | US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders |
| 12/18/2003 | US20030232825 Benzoxazine derivatives and uses thereof |
| 12/17/2003 | CN1462269A Fused azepine drivatives and their use as antidiuretic agents |
| 12/16/2003 | US6664249 Bicyclic vasopressin agonists |
| 12/11/2003 | WO2003101490A1 Drug composition containing calcium channel antagonist |
| 11/27/2003 | WO2003097618A1 Morpholinylmethylureas ccr-3 receptor antagonists |
| 11/20/2003 | WO2003095434A1 Benzoxazine derivatives as 5-ht6 modulators and uses thereof |
| 11/11/2003 | US6645980 Ligands for biological receptors such as opiate receptors or G-protein coupled receptors used for treating pain, drug dependence or tinnitus in mammals |
| 11/11/2003 | US6645958 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists |
| 11/04/2003 | US6642233 Strong affinity and high selectivity for the human NK1 receptors of substance P. |
| 10/28/2003 | US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 10/21/2003 | US6635661 Heterocyclic analgesic compounds and methods of use thereof |
| 10/16/2003 | WO2002100347A3 Prodrugs of gaba analogs, compositions and uses thereof |
| 10/07/2003 | US6630462 Delta agonist analgesics |
| 10/01/2003 | EP1347967A1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 10/01/2003 | CN1122670C Thiazolobenzoheterocycles, prepn method and medicines containing same |
| 09/30/2003 | US6627627 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 09/25/2003 | WO2003077847A2 Substituted amides |
| 09/18/2003 | WO2003076424A1 Macrocyclic compounds useful as pharmaceuticals |
| 09/18/2003 | US20030176668 C-nitroso compounds and use thereof |
| 09/18/2003 | CA2478065A1 Macrocyclic compounds useful as pharmaceuticals |
| 09/17/2003 | CN1121395C Compounds potentiating retinoid |
| 09/10/2003 | EP1341753A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 09/10/2003 | CN1440971A Vitronectin receptor antagnist, its preparation and use |
| 09/04/2003 | US20030166924 Method for extracting a macrolide from biomatter |
| 09/03/2003 | EP1339696A1 Benzyl(idene)-lactams and their use as 5ht1-receptor ligands |
| 09/02/2003 | US6613761 (3R,5S)-N- methanesulfonyl-7-chloro-5-(2,3-dimethoxyphenyl) -1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-1,2,3,5-tetrahydro-4, 1-benzoxazepine-3-acetamide, used as antilipemic agents and enzyme inhibitors |
| 08/28/2003 | WO2003070254A1 Antibiotic conjugates |
| 08/28/2003 | US20030162964 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient |
| 08/28/2003 | CA2476448A1 Antibiotic conjugates |
| 08/21/2003 | WO2003068980A2 Method for extracting a macrolide from biomatter |
| 08/21/2003 | US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa. |
| 08/20/2003 | CN1437587A Benzoxazepinones and their use as squalene synthase inhibitors |
| 08/06/2003 | EP1332763A1 High-density lipoprotein-cholesterol level elevating agent |
| 08/05/2003 | CA2075861C Dibenz[b,f][1,4]oxazepin-11(10h)-ones for multidrug resistance reversing agents |
| 07/30/2003 | EP1330425A2 C-nitroso compounds and use thereof |
| 07/23/2003 | EP0929528B1 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/17/2003 | US20030135042 Atypical antipsychotic agents having low affinity for the D2 Receptor |
| 07/16/2003 | CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/16/2003 | CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/09/2003 | EP1324992A1 Cyclized benzamide neurokinin antagonists for use in therapy |
| 07/09/2003 | EP1324991A1 Compounds useful in the treatment of inflammatory diseases |
| 07/02/2003 | EP1322314A2 Treatment of diabetes mellitus by inhibition of mitochondrial calcium/sodium antiporter |
| 06/26/2003 | US20030119811 Ion channel antagonists that are NMDA antagonists; treatment of migraine, depression, anxiety, schizophrenia, Parkinson's disease, or stroke. |
| 06/18/2003 | EP1318988A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| 06/12/2003 | US20030109524 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists |
| 06/05/2003 | US20030105102 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting PARP activity |
| 05/30/2003 | WO2003043618A2 Amino diols useful in the treatment of alzheimer's disease |
| 05/30/2003 | CA2467476A1 Amino diols useful in the treatment of alzheimer's disease |
| 05/29/2003 | US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy |
| 05/13/2003 | US6562963 Coupling using organosilicon compound |
| 05/13/2003 | US6562813 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 05/01/2003 | US20030083382 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity |
| 04/24/2003 | US20030078251 Triglyceride and cholesterol lowering activity and treats hyperlipidemia |
| 04/23/2003 | EP1304326A1 Single-step process for preparing 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1)hexadeca-1(2)-en-8-ona and obtaining a new form of 9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a |
| 04/10/2003 | US20030069418 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/09/2003 | EP0674623B1 Bicyclic fibrinogen antagonists |
| 03/27/2003 | WO2003024941A1 Naphthalene compounds and use thereof as drugs |
| 03/26/2003 | EP1294698A1 Fused azepine derivatives and their use as antidiuretic agents |
| 03/26/2003 | CN1103775C Vitronectin receptor antagonists, their preparation and use |
| 03/25/2003 | US6538116 For therapy of inflammatory or painful disorder |
| 03/19/2003 | EP1292585A1 Benzoxazepinones and their use as squalene synthase inhibitors |
| 03/13/2003 | US20030050309 A gelatinase inhibitor for modulating the activity of a dopamine, serotonin, or norepinephrine receptor or transporter |
| 03/12/2003 | EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 03/12/2003 | EP1289964A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 03/04/2003 | US6528504 Compounds such as (R)-5,11-dihydro-5-(1-(4-methoxyphenethyl)-piperidine-2-ylmethyl) -dibenzo(b,e)(1,4) oxazepine are useful for treating or preventing abnormal motor functions of gastrointestinal tracts, e.g., irritable bowel syndrome. |
| 03/04/2003 | US6528492 Azithromycin by treating erythromycin A with O-mesitylene sulfonyl hydroxylamine in the presence of sodium bicarbonate to produce 9-deoxo-6-deoxy-6,9-epoxy-9,9a- didehydro-9a-aza-homoerythromycin A intermediate, the 6,9-iminoether |
| 02/27/2003 | WO2003016245A1 Chromatographic separation of enantiomers of protected amino acids via smb-method |
| 02/13/2003 | US20030032635 Heterocyclic esters and amides |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/06/2003 | US20030027807 Vitronectin receptor antagonists, their preparation and their use |
| 01/27/2003 | WO2002010144A1 Single-step process for preparing 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1)hexadeca-1(2)-en-8-ona and obtaining a new form of 9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a |
| 01/22/2003 | EP1276729A1 New neurokinin antagonists for use as medicaments |
| 01/14/2003 | US6506744 Benzazepinone-derivatives |
| 01/14/2003 | CA2141494C Mediators suitable for the electrochemical regeneration of nadh, nadph or analogs thereof |
| 01/09/2003 | WO2003002147A1 Preventives/remedies for organ functional disorders and organ dysfunction |
| 01/09/2003 | CA2451163A1 Agent for preventing or treating organ functional disorders and order dysfunction |
| 01/07/2003 | US6503898 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection |
| 01/03/2003 | WO2003000670A1 A11-piperazinyldibenzo (b, f) (1, 4) oxazepines and thiazepines as atypical antipsychotic agents having low affinity for the d2 receptor |
| 01/03/2003 | WO2002060870A3 Delta agonist analgesics |